发明名称 Antibody fragment-targeted immunoliposomes for systemic gene delivery
摘要 A targeted vector allowing enhanced gene transfer to human hepato-cellular carcinoma (HCC1) cells in vitro was developed using cationic liposomes covalently conjugated with the mAb AF-20. This high affinity antibody recognizes a rapidly internalized 180 kDa cell surface glycoprotein which is abundantly expressed on the surface of human HCC and other cancer cells. Quantitative binding analysis of liposomes with target cells by flow cytometry showed specific association of mAb-targeted liposomes with human HCC cells. Using mAb-targeted cationic liposomes containing 20% DOTAP, in the presence or absence of serum, gene expression in HuH-7 cells was enhanced up to 40-fold as compared to liposomes conjugated with an isotype-matched non-relevant control antibody. Transfection specificity was not observed in a control cell line that does not express the antigen recognized by mAb AF-20. This study demonstrates that cationic liposome formulations can be targeted with monoclonal antibodies (mAbs) to enhance specific in vitro gene delivery and expression in the presence or absence of serum.
申请公布号 US8859274(B2) 申请公布日期 2014.10.14
申请号 US200611591478 申请日期 2006.11.02
申请人 SynerGene Therapeutics, Inc.;Georgetown University 发明人 Xu Liang;Huang Cheng-Cheng;Alexander William;Tang WenHua;Chang Esther H.
分类号 C12N15/00;A01N63/00;A61K48/00;C12N15/86;A61K47/48;A61K9/00;A61K9/127 主分类号 C12N15/00
代理机构 Fanelli Haag & Kilger PLLC 代理人 Fanelli Haag & Kilger PLLC
主权项 1. A plasmid construct for enhanced gene expression in mammalian cells, comprising, from 5′ to 3′: (a) human adenovirus 5 (Ad5) enhancer sequences present in map units 0-1 of Ad5, comprising two copies of Element I and a single copy of Element II; (b) a cytomegalovirus (CMV) promoter; (c) a multiple cloning site; (d) a nucleic acid; and (e) an SV40 poly A sequence;wherein the 3′ end of the plasmid construct does not comprise adenovirus map units 9-16 when compared to wild-type adenovirus.
地址 Washington DC US